Front line results from the DZNE-funded multicenter DEMDAS study identify metabolic syndrome and reduced HDL cholesterol as novel, modifiable risk factors for post-stroke dementia, and reveal distinct profiles for early- and delayed-onset cases, highlighting new opportunities for targeted prevention.